Drug Security Forum

Antibiotics were invented 95 years ago. World medicine has developed a unique opportunity to save lives and defeat deadly diseases in whole or in part. Today, however, antibiotics have become a cause for alarming debate in the medical expert community. Unrestricted use of antibiotics is becoming a global problem and could lead to a fatal reduction in their effectiveness against infectious diseases. To date, around 700,000 people worldwide die each year from infections caused by antibiotic-resistant pathogens. According to some experts, antibiotic resistance could cause 10 million deaths a year by 2050. Compounding the problem is the fact that the global drug market is experiencing a shortage of innovative new drugs to fight the most dangerous and resistant pathogens. What changes to the marketing and prescribing of antibiotics can reverse their overuse? How can control of the circulation of antibiotics in the pharmaceutical market be strengthened, while their production, distribution, and use more carefully regulated? Can epidemiological surveillance limit the uncontrolled use of antibiotics? Will the world be able to withstand the spread of antimicrobial resistance and how will it deal with future infectious diseases?

Moderator
Olga Kobyakova, Director, Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation

Olga Kobyakova

Director, Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation

Panellists
Renad Alyautdin, Head of the Department for Expertise of the Safety of Medicines, Federal State Budgetary Institution "Scientific Center for Expertise of Medicinal Products" of the Ministry of Health of Russia
Oksana Drapkina, Director, National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
Roman Kozlov, Chief Freelance Specialist of the Ministry of Health of the Russian Federation for Clinical Microbiology and Antimicrobial Resistance; President, Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC)
Yury Lobzin, Children’s Clinical Research Centre for Infectious Diseases, Federal Biomedical Agency
Yulia Mihaleva, Deputy Director, Russian Quality System (Roskachestvo)
Alla Samoylova, Head, Federal Service for Surveillance in Healthcare (Roszdravnadzor)

Renad Alyautdin

Head of the Department for Expertise of the Safety of Medicines, Federal State Budgetary Institution "Scientific Center for Expertise of Medicinal Products" of the Ministry of Health of Russia

Oksana Drapkina

Director, National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation

Doctor of medical Sciences, Professor, corresponding member of RAS
Oksana M. graduated from the MMA named after I. M. Sechenov in 1992. From 1992 to 1997 she worked in the intensive care unit of the clinic of internal diseases of MMA named after I. M. Sechenov. From 1997 to 2015 she worked at the Department of internal medicine propaedeutics First Moscow State Medical University named after I. M. Sechenov, where she was promoted from Department assistant to Professor. In 2013, she was Awarded the Russian government prize in the field of education. In 2017 she was appointed to the position of Director of "NMRC PM" of the Ministry of health of Russia.
Professor Drapkina combines ongoing clinical work with research activities.
Awards: diploma of the Ministry of health of Russia, Laureate of the Russian Government prize in education, badge " excellence in health care».
There were defended 16 PhD theses and 1 dissertation for the degree of doctor of medical Sciences under the scientific guidance of O. M. Drapkina, more than 600 scientific article were published in domestic and foreign journals, 7 monographs, 10 textbooks

Roman Kozlov

Chief Freelance Specialist of the Ministry of Health of the Russian Federation for Clinical Microbiology and Antimicrobial Resistance; President, Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC)

Yury Lobzin

Children’s Clinical Research Centre for Infectious Diseases, Federal Biomedical Agency

Yulia Mihaleva

Deputy Director, Russian Quality System (Roskachestvo)

Alla Samoylova

Head, Federal Service for Surveillance in Healthcare (Roszdravnadzor)

Born in Cheboksary.
1990: Graduated from the Chuvash State University named after I. N. Ulyanov with a degree in medicine.
2002: Awarded with the badge “Excellent Worker of Public Health”.
2007: Honored doctor of the Chuvash Republic.
2010: Doctor of Science in medicine.
2012: Professor of obstetrics and gynecology.
1987-1990 – nurse, obstetrician-gynecologist at the industrial hospitals in Cheboksary.
1990-1993 – Full-time postgraduate study at Chuvash State University.
1993-1994 - Assistant at the Obstetrics and Gynecology Department of the Chuvash State University.
1994-2012 – Chief Doctor of the Presidential Perinatal Center of the Ministry of Health and social development of the Chuvash Republic.
2010-2017 – Head of the Department of Obstetrics and Gynecology named after G. M. Vorontsova, of the Chuvash State University.
2012-2015 – Deputy Chair at the Cabinet of Ministers of the Chuvash Republic - Minister of Health and Social Development of the Chuvash Republic.
2015-2017 – Minister of Health of the Chuvash Republic.
2018-2019 – Adviser to the Head of the Federal Service for Surveillance in Healthcare.
2019-2020 – Head of the Department of State Control of Implementation of State Healthcare Programs, the Federal Service for Surveillance in Healthcare.
2020 – Director of the Project Activities Department, the Ministry of Health of the Russian Federation.
Since April 10, 2020 - Head of the Federal Service for Surveillance in Healthcare.